Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

3 Sep 2015
Change (% chg)

$-3.71 (-7.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ESPR.OQ


Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardio-metabolic risk markers. The Company's primary activities include conducting... (more)


Beta: --
Market Cap(Mil.): $1,101.72
Shares Outstanding(Mil.): 22.49
Dividend: --
Yield (%): --


  ESPR.OQ Industry Sector
P/E (TTM): -- 67.43 35.59
EPS (TTM): -2.23 -- --
ROI: -23.14 0.53 14.96
ROE: -23.67 0.40 15.84
Search Stocks

Wal-Mart, materials shares drag Wall St. lower

- U.S. stocks fell on Tuesday, with the S&P 500 trading in its tightest daily range in nearly a month, weighed down by earnings-related selling in Wal-Mart and a drop in commodity stocks on concerns about China's economy. | Video

18 Aug 2015

Esperion drug lowers cholesterol in patients taking statins

- Esperion Therapeutics Inc said its experimental drug lowered LDL or "bad" cholesterol levels in patients who were already on statins, the current standard of care.

17 Mar 2015

UPDATE 2-Esperion drug lowers cholesterol in patients taking statins

* Says will look for partner to commercialize drug outside US

17 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks